Temporizin and Temporizin-1 Peptides as Novel Candidates for Eliminating Trypanosoma cruzi

• André L. A. Souza ,

  Contributed equally to this work with: André L. A. Souza, Robson X. Faria

  Affiliations FIOCRUZ, Center for Technological Development in Health (CDTS)/National Institute of Science and Technology for Innovation on Neglected Diseases (INCT-IDN), Rio de Janeiro, RJ, Brazil, FIOCRUZ, Oswaldo Cruz Institute, Laboratory of Experimental and Computational Biochemistry of Pharmaceuticals, Rio de Janeiro, RJ, Brazil

  ⨯
• Robson X. Faria ,

  Contributed equally to this work with: André L. A. Souza, Robson X. Faria

  * E-mail: robson.xavier@gmail.com

  Affiliation FIOCRUZ, Oswaldo Cruz Institute, Laboratory of Toxoplasmosis and other Protozoosis, Rio de Janeiro, RJ, Brazil

  ⨯
• Kátia S. Calabrese,

  Affiliation FIOCRUZ, Oswaldo Cruz Institute, Laboratory of Imunomodulation and Protozoology, Rio de Janeiro, RJ, Brazil

  ⨯
• Daiane J. Hardoim,

  Affiliation FIOCRUZ, Oswaldo Cruz Institute, Laboratory of Imunomodulation and Protozoology, Rio de Janeiro, RJ, Brazil

  ⨯
• Noemi Taniwaki,

  Affiliation FIOCRUZ, Adolfo Lutz Institute, Electronic Microscopy section, Araçatuba, São Paulo, SP, Brazil

  ⨯
• Luiz A. Alves,

  Affiliation FIOCRUZ, Oswaldo Cruz Institute, Laboratory of Cellular Communication, Rio de Janeiro, RJ, Brazil

  ⨯
• Salvatore G. De Simone

  Affiliations FIOCRUZ, Center for Technological Development in Health (CDTS)/National Institute of Science and Technology for Innovation on Neglected Diseases (INCT-IDN), Rio de Janeiro, RJ, Brazil, Federal Fluminense University, Biology Institute, Department of Cellular and Molecular Biology, Niterói, RJ, Brazil

  ⨯